A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols.
Saved in:
| Title: | A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols. |
|---|---|
| Authors: | Chisari CG; Department of Medical and Surgical Sciences and Advanced Technologies 'GF Ingrassia', Multiple Sclerosis Center, University of Catania, Catania, Italy., Guadagno J; Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Adjamian P; GW Pharmaceuticals, Cambridge, UK.; Jazz Pharmaceuticals, Inc., Dublin, Ireland., Vila Silvan C; Almirall SA, Barcelona, Spain., Greco T; Jazz Pharmaceuticals - Gentium Srl, Villa Guardia, Italy., Bagul M; GW Pharmaceuticals, Cambridge, UK.; Jazz Pharmaceuticals, Inc., Dublin, Ireland., Patti F; Department of Medical and Surgical Sciences and Advanced Technologies 'GF Ingrassia', Multiple Sclerosis Center, University of Catania Italy. |
| Source: | Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2023 Sep 21; Vol. 16, pp. 17562864231195513. Date of Electronic Publication: 2023 Sep 21 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Country of Publication: England NLM ID: 101480242 Publication Model: eCollection Cited Medium: Print ISSN: 1756-2856 (Print) Linking ISSN: 17562856 NLM ISO Abbreviation: Ther Adv Neurol Disord Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
